Form 4: CVS Health Executive Heidi B. Capozzi Reports Acquisition of Restricted Stock Units

CVS Health's Executive Vice President and Chief People Officer, Heidi B. Capozzi, acquired 83,542 restricted stock units on November 30, 2024.

Summary

• Heidi B. Capozzi, Executive Vice President and Chief People Officer at CVS Health, reported the acquisition of 83,542 restricted stock units.
• The transaction occurred on November 30, 2024, at a price of $59.85 per unit.
• These restricted stock units were awarded under the company's 2017 Incentive Compensation Plan.
• The restrictions on these units will lapse in four equal installments, starting on November 30, 2025.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns executive interests with company performance. There are no negative implications.

Positives

• The acquisition of restricted stock units by a key executive signals confidence in the company's future performance.
• The vesting schedule of the restricted stock units, starting in 2025, aligns executive interests with long-term company success.

Future Outlook

The restricted stock units will vest in four equal installments starting November 30, 2025, indicating a long-term incentive structure.

Industry Context

This type of stock-based compensation is common in the industry to align executive interests with shareholder value and long-term company performance.

Comparison to Industry Standards

• Stock-based compensation is a standard practice among large publicly traded companies like CVS Health, including competitors such as Walgreens Boots Alliance and UnitedHealth Group.
• The vesting schedule of four equal installments is a typical approach to ensure long-term commitment from executives.
• The value of the restricted stock units is consistent with market rates for executive compensation in the healthcare sector.

Stakeholder Impact

• The acquisition of restricted stock units by a key executive can positively impact shareholder confidence.
• The vesting schedule of the restricted stock units aligns executive interests with long-term company success, which benefits shareholders.

Key Dates

Keywords

restricted stock units, executive compensation, CVS Health, insider trading, incentive compensation, equity securities